Panel Discussion: Identifying & Validating a Novel Therapy to Complement SGLT2 Inhibitors

Time: 9:30 am
day: Day Two


  • Defining the next wave of therapeutics discovery after SGLT2i to improve clinical outcomes
  • Measuring incremental benefit of novel therapeutics in addition to SGLT2 inhibitors
  • Optimizing a smart preclinical screening platform to monitor efficacy in addition to standard of care
  • Considering innovative trial design and untraditional endpoints to demonstrate efficacy and meet regulatory requirements